Compugen (CGEN)
1.89
-0.01 (0.53%)
Upcoming Events
Latest Headlines
Compugen (CGEN) PT Lowered to $29 at H.C. Wainwright
April 16, 2024 12:16 PM - StreetInsider
Compugen (CGEN) Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503
April 10, 2024 7:12 AM - StreetInsider
Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503
April 10, 2024 7:00 AM - PR NewsWire
Compugen to Participate in Two Upcoming Investor Conferences
April 3, 2024 7:00 AM - PR NewsWire
Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy
March 11, 2024 7:00 AM - PR NewsWire
Compugen (CGEN) PT Raised to $5 at Truist Securities
March 8, 2024 7:05 AM - StreetInsider
Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024
March 6, 2024 7:00 AM - PR NewsWire
Form 20-F COMPUGEN LTD For: Dec 31
March 5, 2024 4:07 PM - SEC Filing
Compugen (CGEN) Tops Q4 EPS by 1c
March 5, 2024 7:02 AM - StreetInsider
Form 6-K COMPUGEN LTD For: Mar 05
March 5, 2024 7:00 AM - SEC Filing
Compugen Reports Fourth Quarter and Full Year 2023 Results
March 5, 2024 7:00 AM - PR NewsWire
Compugen to Present at the Leerink Partners Global Biopharma Conference 2024
February 26, 2024 7:00 AM - PR NewsWire
Compugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024
February 20, 2024 7:00 AM - PR NewsWire
Compugen (CGEN) Appoints Michelle Mahler as Chief Medical Officer
February 15, 2024 7:02 AM - StreetInsider
Form 6-K COMPUGEN LTD For: Feb 15
February 15, 2024 7:01 AM - SEC Filing
Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer
February 15, 2024 7:00 AM - PR NewsWire
Full Article List
